Stocks · Korea
260660
KOSDAQ
Korea Arlico Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+3.05%
1M-4.44%
3M-4.83%
6M-30.95%
1Y-46.49%
YTD-46.25%
52W high5,760원
52W low2,150원
From 52W high-58.94%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,677억 | 99억 | 80억 | 5.9% |
| 2023 | 1,872억 | 31억 | 31억 | 1.6% |
| 2024 | 1,904억 | -52억 | -54억 | -2.7% |
| 2025 | 2,012억 | 10억 | -6억 | 0.5% |
| Quarterly | ||||
| 2024 4Q | 523억 | -6억 | -17억 | -1.2% |
| 2025 1Q | 504억 | 10억 | 4억 | 2.0% |
| 2025 2Q | 503억 | 17억 | 5억 | 3.3% |
| 2025 3Q | 1,025억 | 17억 | -21,000,551원 | 1.6% |
| 2025 4Q | -20억 | -34억 | -15억 | — |
| 2026 1Q | 483억 | -18억 | -6억 | -3.6% |
Company
Address: 서울특별시 서초구 바우뫼로27길 7-21 (양재동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.